Diagonal Bio AB (publ)

    Diagonal Bio AB (publ)

    SSTO:DIABIO
    - -
    SEK
    - -
    - -
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    - -
    0.06
    0.02
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -1.7
    -1.7
    -0.32
    -0.04
    -0.01
    Free Cash Flow per Basic Share
    - -
    -2.84
    -2.18
    -0.26
    -0.06
    -0.01
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    -3.77
    -4.68
    -1.64
    -0.18
    -0.05
    Tangible Book Value per Share
    - -
    2.81
    1.23
    -0.07
    - -
    - -
    Basic Weighted Avg Shares
    - -
    7
    9
    36
    276
    987
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    -2,865.6
    -7,469.46
    -50,291.3
    -15,195.16
    -3,243.69
    Depreciation Expense
    - -
    - -
    - -
    - -
    1
    1
    Net Income, GAAP
    - -
    -12
    -16
    -12
    -10
    -9
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -2,865.6
    -7,962.56
    -50,773.91
    -16,016.13
    -3,222.87
    Working Capital
    3
    19
    12
    -3
    - -
    2
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    9
    34
    31
    21
    25
    27
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1,215
    1,430
    1,634
    Market Capitalization
    7
    10
    - -

    Working Capital

    SEK

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    6
    6
    4
    Cash, Cash Equivalents & STI
    5
    3
    2
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    1
    2
    2
    Total Current Liabilities
    3
    3
    2
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    15.75%
    Free Cash Flow
    - -
    - -
    62.83%
    Net Income, GAAP
    - -
    - -
    -14.97%
    Sales/Revenue/Turnover
    - -
    - -
    169.57%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.11
    -0.08
    -0.08
    -0.06
    -0.32
    2024
    -0.07
    -0.01
    - -
    -0.01
    -0.04
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business